[Blood hypercoagulability with administration of norethynodrel: correction for purification of progestin].

P. Brazeau,M. Dansereau,M. Gervais,R. Banerjee
DOI: https://doi.org/10.1139/Y73-082
1973-07-01
Canadian Journal of Physiology and Pharmacology
Abstract:Blood clotting induced by non-purified norethynodrel is no longer observed in adult female rats when purified norethynodrel (99.7% pure) is used. Analysis of the times of bleeding and of coagulation of these rats treated with purified and non-purified norethynodrel clearly demonstrate that the purification of progestin eliminates the thromboembolic side effects. It is debated whether or not the concentration of estrogens can fully explain these side effects associated with the use of oral contraceptives. Furthermore, degradation products and/or contaminants during synthesis of this progestin would be, in large part, responsible for this blood clotting side effect in the female rat.
What problem does this paper attempt to address?